Precision Health
Transforming care through data-driven, personalized approaches that predict, prevent, and treat disease at the individual level.
Personalized. Predictive. Preventive. Global.
Anuvansh helps health systems and patients shift from reactive to proactive care by integrating genomics, clinical data, and predictive insights. This enables personalized care at scale in the U.S. and expands access to early detection in India.
Cancer is primarily a genetic disease, driven by unique mutations that vary dramatically from patient to patient. These genetic alterations can manifest as single-nucleotide variants, gene amplifications, chromosomal rearrangements, or pathway deregulation. This complexity underscores the need for comprehensive genomic profiling to inform precision care.
Our Vision
Our goal is to deliver personalized, proactive, and evolving cancer care that adapts to each patient’s unique biology—turning genomic insight into therapeutic impact.
Precision health is about understanding the individual, not just the population. We combine genetics, lab values, claims data, and lifestyle factors to provide actionable, person-level health insight.
What We Offer
Anuvansh integrates cutting-edge genomic tools—including DNA/RNA sequencing, multi-gene panels, epigenetic profiling, and biomarker analysis—to deeply characterize an individual’s genetic and clinical landscape. Our comprehensive approach enables precise, actionable insights across multiple domains:
Pharmacogenomics :
- Inform drug selection and optimize dosing through integrated PGx insights, significantly reducing adverse drug events, trial-and-error prescribing, and drug inefficacy.
Clinomics Fusion Dashboards
- Seamlessly unify sequencing data with electronic health records (EHR) and laboratory results, providing clear and dynamic views of patient risk and tailored care options.
- Identify inherited risks for cancer, cardiovascular diseases, and neurodegenerative disorders using variant-based models and polygenic risk scores
- Integrate genomic, epigenomic, and imaging data longitudinally, capturing dynamic tumor evolution, treatment response, and emerging resistance mechanisms
Preventive Pathways
- Develop personalized, evidence-based screening and preventive strategies precisely aligned with a patient’s genetic and phenotypic profiles.
- Implement tailored lifestyle and dietary interventions to proactively manage genetic predispositions.
- Leverage continuous risk monitoring to adapt preventive strategies dynamically throughout a patient’s life.
Targeted Therapies
- Match patients to highly effective therapies, such as HER2 inhibitors (breast and gastric cancers).
- Employ expert-driven, AI-enhanced analysis to differentiate pathogenic genetic alterations from benign variants, providing clinicians with clear, actionable genomic guidance.
At Anuvansh, we bridge state-of-the-art genomic research with clinical practice, empowering healthcare providers and patients with precision-driven, personalized care.